Skip to Main Content

A Dose Ranging Study Evaluating Efficacy and Safety of NI-03


Diseases of the Digestive System - Pancreas | Diseases of the Endocrine System

Phase I-II

What is the purpose of this trial?

The purpose of this study is to determine the safety and efficacy of NI-03.

  • Trial with
    Stason Pharmaceuticals, Inc.
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC